These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 10220746)
1. Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Okano J; Shiota G; Kawasaki H Liver; 1999 Apr; 19(2):151-9. PubMed ID: 10220746 [TBL] [Abstract][Full Text] [Related]
2. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma]. Wu FS; Zheng SS; Wu LJ; Ding W; Ma ZM; Wang ZM; Teng LS; Zhao WH Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):603-8. PubMed ID: 16784653 [TBL] [Abstract][Full Text] [Related]
3. Significance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection. Chau GY; Lui WY; Chi CW; Chau YP; Li AF; Kao HL; Wu CW Eur J Surg Oncol; 2008 Mar; 34(3):333-8. PubMed ID: 17218078 [TBL] [Abstract][Full Text] [Related]
4. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor and c-met expression in Long-Evans Cinnamon rats with spontaneous hepatitis and hepatoma. Nakayama N; Kashiwazaki H; Kobayashi N; Hamada JI; Ogiso Y; Itakura Y; Matsumoto K; Nakamura T; Koike T; Kuzumaki N; Takeichi N Hepatology; 1996 Sep; 24(3):596-602. PubMed ID: 8781331 [TBL] [Abstract][Full Text] [Related]
7. Expression of HGF, its receptor c-met, c-myc, and albumin in cirrhotic and neoplastic human liver tissue. Ljubimova JY; Petrovic LM; Wilson SE; Geller SA; Demetriou AA J Histochem Cytochem; 1997 Jan; 45(1):79-87. PubMed ID: 9010472 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma. Osada S; Kanematsu M; Imai H; Goshima S Hepatogastroenterology; 2008; 55(82-83):544-9. PubMed ID: 18613405 [TBL] [Abstract][Full Text] [Related]
9. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases. Shiota G; Umeki K; Okano J; Kawasaki H J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905 [TBL] [Abstract][Full Text] [Related]
10. Liver hepatocyte growth factor does not always correlate with hepatocellular proliferation in human liver lesions: its specific receptor c-met does. D'Errico A; Fiorentino M; Ponzetto A; Daikuhara Y; Tsubouchi H; Brechot C; Scoazec JY; Grigioni WF Hepatology; 1996 Jul; 24(1):60-4. PubMed ID: 8707284 [TBL] [Abstract][Full Text] [Related]
11. Expression of hepatocyte growth factor and its receptor, the c-met proto-oncogene, in hepatocellular carcinoma. Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E Hepatology; 1997 Mar; 25(3):619-23. PubMed ID: 9049208 [TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma. Ueki T; Fujimoto J; Suzuki T; Yamamoto H; Okamoto E Hepatology; 1997 Apr; 25(4):862-6. PubMed ID: 9096589 [TBL] [Abstract][Full Text] [Related]
13. Detection of serum and intrahepatic human hepatocyte growth factor in patients with type C liver diseases. Yamagami H; Moriyama M; Tanaka N; Arakawa Y Intervirology; 2001; 44(1):36-42. PubMed ID: 11223718 [TBL] [Abstract][Full Text] [Related]
14. C-met and hepatocyte growth factor expression in combined hepatocellular and cholangiocarcinoma. Varnholt H; Asayama Y; Aishima S; Taguchi K; Sugimachi K; Tsuneyoshi M Oncol Rep; 2002; 9(1):35-41. PubMed ID: 11748452 [TBL] [Abstract][Full Text] [Related]
15. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines. Efimova EA; Glanemann M; Liu L; Schumacher G; Settmacher U; Jonas S; Langrehr JM; Neuhaus P; Nüssler AK Eur Surg Res; 2004; 36(5):300-7. PubMed ID: 15359093 [TBL] [Abstract][Full Text] [Related]
16. [Expression of hepatocyte growth factor/c-Met system in nasopharyngeal carcinoma and its biological significance]. Li Z; Lin SX; Liang HZ; He JH Zhonghua Bing Li Xue Za Zhi; 2005 Feb; 34(2):75-9. PubMed ID: 15842800 [TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development. Ishikawa KS; Masui T; Ishikawa K; Shiojiri N Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Nakashiro K; Hayashi Y; Oyasu R Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672 [TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of human hepatocyte growth factor is a useful indicator for predicting the occurrence of hepatocellular carcinomas in C-viral chronic liver diseases. Yamagamim H; Moriyama M; Matsumura H; Aoki H; Shimizu T; Saito T; Kaneko M; Shioda A; Tanaka N; Arakawa Y Cancer; 2002 Aug; 95(4):824-34. PubMed ID: 12209727 [TBL] [Abstract][Full Text] [Related]
20. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor. Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]